CASM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CASM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. CAS Medical Systems's annualized return on capital (ROC %) for the quarter that ended in Dec. 2018 was -100.62%.
As of today (2024-05-05), CAS Medical Systems's WACC % is 0.00%. CAS Medical Systems's ROC % is 0.00% (calculated using TTM income statement data). CAS Medical Systems earns returns that do not match up to its cost of capital. It will destroy value as it grows.
The historical data trend for CAS Medical Systems's ROC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAS Medical Systems Annual Data | |||||||||||||||||||||
Trend | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | |||||||||||
ROC % | Get a 7-Day Free Trial | -91.22 | -75.53 | -58.94 | -76.48 | -81.03 |
CAS Medical Systems Quarterly Data | ||||||||||||||||||||
Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | |
ROC % | Get a 7-Day Free Trial | -86.97 | -75.70 | -84.73 | -81.96 | -100.62 |
CAS Medical Systems's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2018 is calculated as:
ROC % (A: Dec. 2018 ) | ||||||
= | NOPAT | / | Average Invested Capital | |||
= | Operating Income * ( 1 - Tax Rate % ) | / | ( (Invested Capital (A: Dec. 2017 ) | + | Invested Capital (A: Dec. 2018 )) | / count ) |
= | -4.491 * ( 1 - 0% ) | / | ( (6.104 | + | 4.981) | / 2 ) |
= | -4.491 | / | 5.5425 | |||
= | -81.03 % |
where
Invested Capital | (A: Dec. 2017 ) | |||||||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | Excess Cash | |||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | ( Cash, Cash Equivalents, Marketable Securities | - | max(0, Total Current Liabilities | - | Total Current Assets | + | Cash, Cash Equivalents, Marketable Securities | )) |
= | 12.975 | - | 2.068 | - | ( 5.653 | - | max(0, 5.198 | - | 10.001 | + | 5.653 | )) |
= | 6.104 |
Invested Capital | (A: Dec. 2018 ) | |||||||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | Excess Cash | |||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | ( Cash, Cash Equivalents, Marketable Securities | - | max(0, Total Current Liabilities | - | Total Current Assets | + | Cash, Cash Equivalents, Marketable Securities | )) |
= | 10.85 | - | 2.597 | - | ( 3.272 | - | max(0, 3.473 | - | 8.087 | + | 3.272 | )) |
= | 4.981 |
CAS Medical Systems's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2018 is calculated as:
ROC % (Q: Dec. 2018 ) | ||||||
= | NOPAT | / | Average Invested Capital | |||
= | Operating Income * ( 1 - Tax Rate % ) | / | ( (Invested Capital (Q: Sep. 2018 ) | + | Invested Capital (Q: Dec. 2018 )) | / count ) |
= | -4.972 * ( 1 - 0% ) | / | ( (4.902 | + | 4.981) | / 2 ) |
= | -4.972 | / | 4.9415 | |||
= | -100.62 % |
where
Invested Capital | (Q: Sep. 2018 ) | |||||||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | Excess Cash | |||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | ( Cash, Cash Equivalents, Marketable Securities | - | max(0, Total Current Liabilities | - | Total Current Assets | + | Cash, Cash Equivalents, Marketable Securities | )) |
= | 11.734 | - | 2.97 | - | ( 3.862 | - | max(0, 3.038 | - | 8.948 | + | 3.862 | )) |
= | 4.902 |
Invested Capital | (Q: Dec. 2018 ) | |||||||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | Excess Cash | |||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | ( Cash, Cash Equivalents, Marketable Securities | - | max(0, Total Current Liabilities | - | Total Current Assets | + | Cash, Cash Equivalents, Marketable Securities | )) |
= | 10.85 | - | 2.597 | - | ( 3.272 | - | max(0, 3.473 | - | 8.087 | + | 3.272 | )) |
= | 4.981 |
Note: The Operating Income data used here is four times the quarterly (Dec. 2018) data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CAS Medical Systems (NAS:CASM) ROC % Explanation
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, CAS Medical Systems's WACC % is 0.00%. CAS Medical Systems's ROC % is 0.00% (calculated using TTM income statement data). CAS Medical Systems earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Thank you for viewing the detailed overview of CAS Medical Systems's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Alan Milinazzo | director | C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078 |
Thomas M Patton | director, officer: President and CEO | C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724 |
Kenneth R Weisshaar | director | 875 PARK AVE APT 2D, NEW YORK NY 10021 |
James E Thomas | director, 10 percent owner | WOODS END ROAD, NEW CANAAN CT 06840 |
Thomas, Mcnerney & Partners Ii L.p. | 10 percent owner | 45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402 |
Tmp Associates Ii Lp | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Tmp Nominee Ii, Llc | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Thomas, Mcnerney & Partners Ii, Llc | 10 percent owner | 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402 |
Acuta Capital Fund, Lp | 10 percent owner | 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 |
James E Flynn | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Management Company, L.p. (series C) | 10 percent owner, other: Possible Member of 10% Group | 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010 |
Deerfield Mgmt L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Special Situations Fund, L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Deerfield Special Situations International Master Fund, L.p. | 10 percent owner, other: Possible Member of 10% Group | 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017 |
Lawrence Burstein | director | C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016 |
From GuruFocus
By Marketwired Marketwired • 05-29-2018
By PRNewswire PRNewswire • 03-14-2019
By gurufocus • 08-12-2009
By Marketwired Marketwired • 05-03-2018
By PRNewswire PRNewswire • 02-12-2019
By GuruFocus Research GuruFocus Editor • 12-08-2010
By PRNewswire PRNewswire • 03-19-2019
By gurufocus 10qk • 08-04-2010
By Marketwired Marketwired • 11-13-2018
By gurufocus • 05-07-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.